Treatment with inhibitors of the NF-κB pathway improves whole body tension development in the mdx mouse

Neuromuscular Disorders

Volumn 19, Issue 2, 2009, Pages 131-139

  Siegel, Ashley L ^a   Bledsoe, Cathy ^a   Lavin, Jesse ^a   Gatti, Francesca ^a   Berge, Jonas ^a   Millman, Gregory ^a   Turin, Eric ^a   Winders, W Tyler ^a   Rutter, John ^a   Palmeiri, Beniamino ^b   Carlson, C George ^a  

^a A T STILL UNIVERSITY   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Mdx mouse; Muscle function; Muscular dystrophy; NF B; Pyrollidine dithiocarbamate; Ursodeoxycholic acid; Whole body tension

Indexed keywords

PYRROLIDINE DITHIOCARBAMATE; SYNAPTOTAGMIN I; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM; DRUG EFFECT; DRUG EFFICACY; FEMALE; GROUPS BY AGE; LIFESPAN; LIMB WEAKNESS; MALE; MOUSE; MUSCLE FUNCTION; MUSCLE TONE; MUSCULAR DYSTROPHY; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TREATMENT DURATION; TREATMENT OUTCOME; UPREGULATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; ANTIOXIDANTS; CHOLAGOGUES AND CHOLERETICS; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, INBRED MDX; MUSCLE STRENGTH; MUSCLE STRETCHING EXERCISES; MUSCLE TONUS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NF-KAPPA B; PYRROLIDINES; RECOVERY OF FUNCTION; THIOCARBAMATES; TRANSCRIPTION FACTOR RELA; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 59149089897     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.10.006     Document Type: Article

References (30)

1. Bulfield G., Siller W.G., Wright P.A.L., and Moore K.J. X-chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81 (1984) 1189-1192
2. Hoffman E.P., Brown R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
3. Carlson C.G., and Makiejus R.V. A non-invasive procedure to detect muscle weakness in the mdx mouse. Muscle Nerve 13 (1990) 480-484
4. Dupont-Versteegden E.E., and McCarter R.J. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 15 (1992) 1105-1110
5. Hudecki M.S., Pollina C.M., Granchelli J.A., Daly M.K., Byrnes T., Wang J.C., et al. Strength and endurance in the therapeutic evaluation of prednisolone-treated mdx mice. Res Commun Chem Pathol Pharmacol 79 (1993) 45-60
6. Muntoni F., Mateddu A., Marchei F., Clerk A., and Serra G. Muscular weakness in the mdx mouse. J Neurol Sci 120 (1993) 71-77
7. Quinlan J.G., Johnson S.R., McKee M.K., and Lyden S.P. Twitch and tetanus in mdx mouse muscle. Muscle Nerve 15 (1992) 837-842
8. Torres L.F.B., and Duchen L.W. The mutant mdx: inherited myopathy in the mouse. Brain 110 (1987) 269-299
9. Matsuda R., Nishikawa A., and Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans Blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem 118 (1995) 959-964
10. Carnwath J.W., and Shotton D.M. Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 80 (1987) 39-54
11. Tanabe Y., Esaki K., and Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 69 (1986) 91-95
12. Chen Y.-W., Nagaraju K., Bakay M., McIntyre O., Rawat R., Shi R., et al. Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy. Neurology 65 (2005) 826-834
13. Porter J.D., Khanna S., Kaminski H.J., Rao J.S., Merriam A.P., Richmonds C.R., et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11 (2002) 263-272
14. Kumar A., and Boriek A.M. Mechanical stress activates the nuclear factor-kappa B pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 17 (2003) 296-386
15. Monici M.C., Aguennouz M., Mazzeo A., Messina C., and Vita G. Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 60 (2003) 993-997
16. 2+ influx is not increased in a severely dystrophic expiratory muscle (triangularis sterni) of the mdx mouse. Neurobiol Dis 14 2 (2003) 229-239
17. Carlson C.G., Samadi A., and Siegel A. Chronic treatment with agents that stabilize cytosolic IκBα enhance survival and improve resting potential in mdx muscle fibers subjected to chronic passive stretch. Neurobiol Dis 20 3 (2005) 719-730
18. Messina S., Bitto A., Aguennouz M., Minutoli L., Monici M.C., Altavilla D., et al. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 198 (2006) 234-241
19. Pan Y., Chen C., Shen Y., Zhu C.-H., Wang G., Wang X.-C., et al. Curcumin alleviates dystrophic pathology in mdx mice. Mol Cell 25 4 (2008) 531-537
20. Acharyya S., Villalta A., Bakkar N., Bupha-Intr T., Janssen P.M.L., Carathers M., et al. Interplay of IKK/NF-κB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117 (2007) 889-901
21. Deconinck N., Tinsley J., De Backer F., Fisher R., Kahn D., Phelps S., et al. Expression of truncated utrophin leads to major functional improvements in dystrophin deficient muscles of mice. Nat Med 11 (1997) 1216-1221
22. Makiejus R.V., Patel V.K., Krishna G., Dierdorf S.F., and Bonsett C. Effect of adenylosuccinate on the strength of dystrophin lacking muscles of mdx mice. Biochem Arch 7 (1991) 95-103
23. Gillis J. Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse. Neuromuscul Disord 12 (2002) S90-S94
24. Miura T., Ouchida R., Yoshikawa N., Okamoto K., Makino Y., Nakamura T., et al. Functional modification of the glucocorticoid receptor and suppression of NF-kappa-B dependent transcription by ursodeoxycholic acid. J Biol Chem 276 50 (2001) 47371-47378
25. De Bosscher K., Berghe W.V., and Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24 4 (2003) 488-522
26. Cuzzocrea S., Chatterjee P.K., Mazzon E., Dugo L., Serraino I., Britti D., et al. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Brit J Pharmacol 135 (2002) 496-510
27. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., et al. Evidence that reactive oxygen species do not mediate NF-κB activation. EMBO J 22 13 (2003) 3356-3366
28. Durham W.J., Arbogast S., Gerken E., Li Y.-P., and Reid M.B. Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice. Muscle Nerve 34 (2006) 298-303
29. Millman GW, Turin EC, Samadi A, Carlson CG. The NF-kappaB pathway in dystrophic (mdx) skeletal muscle produces elevated active p65 in the nuclear compartment without altering the subcellular distribution of the transcription factor. American Society Cell Biology Abstracts 2007; # 1823:499.
30. Tinsley J., Deconinck N., Fisher R., Kahn D., Phelps S., Gillis J.-M., and Davies K. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4 12 (1998) 1441-1444